Birth Control Pill Recall
Written by Faith Anderson on February 28, 2012
Products Affected by Birth Control Pill Recall
Glenmark Generics, the India-based drug company, has warned consumers that seven lots of norgestimate and ethinyl estradiol were affected by the packaging error, which “could leave women without adequate contraception, and at risk for unintended pregnancy.” The tablets were distributed to U.S. pharmacies between September 21 and December 30, 2011, and the affected lot numbers of the birth control pill are 04110101, 04110106, 04110107, 04110114, 04110124, 04110129 and 04110134.
Recommendations for Consumers
The correct packaging for Glenmark’s norgestimate and ethinyl estradiol aligns 28 tablets in four rows, with white norgestimate and ethinyl estradiol-containing tablets in the top row and light green placebo tablets in the bottom row. “Patients who have the affected product should notify their physician and return the product to the pharmacy,” Glenmark Generics warned, adding that affected consumers should “begin using a nonhormonal form of contraception immediately.”